SUMO-1 conjugation blocks beta-amyloid-induced astrocyte reactivity

Neuroscience Letters

Volumn 546, Issue , 2013, Pages 51-56

  Hoppe, Juliana B ^a,b   Rattray, Marcus ^a,c   Tu, Henry ^a   Salbego, Christianne G ^b   Cimarosti, Helena ^a  

^a UNIVERSITY OF READING   (United Kingdom)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^c UNIVERSITY OF BRADFORD   (United Kingdom)

Author keywords

Alzheimer's disease; Beta amyloid peptide; C Jun N terminal kinase; Curcumin; Reactivity; Small ubiquitin like modifier (SUMO) conjugation

Indexed keywords

AMYLOID BETA PROTEIN; CURCUMIN; GLIAL FIBRILLARY ACIDIC PROTEIN; STRESS ACTIVATED PROTEIN KINASE; SUMO 1 PROTEIN;

ANIMAL CELL; ANIMAL CELL CULTURE; ARTICLE; ASTROCYTE; CELL ACTIVATION; CELL STRUCTURE; CONJUGATION; IN VITRO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; REGULATORY MECHANISM; SUMOYLATION;

AMYLOID BETA-PEPTIDES; ANIMALS; ASTROCYTES; CELLS, CULTURED; CURCUMIN; DRUG INTERACTIONS; ENZYME ACTIVATION; MAP KINASE KINASE 4; MICE; SUMO-1 PROTEIN; SUMOYLATION;

EID: 84878917533     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2013.04.050     Document Type: Article

References (31)

1. Abeti R., Abramov A.Y., Duchen M.R. Beta-amyloid activates PARP causing astrocytic metabolic failure and neuronal death. Brain 2011, 134:1658-1672.
2. Abramov A.Y., Canevari L., Duchen M.R. Beta-amyloid peptides induce mitochondrial dysfunction and oxidative stress in astrocytes and death of neurons through activation of NADPH oxidase. J. Neurosci. 2004, 24:565-575.
3. Akar C.A., Feinstein D.L. Modulation of inducible nitric oxide synthase expression by sumoylation. J. Neuroinflamm. 2009, 6:12.
4. Allaman I., Gavillet M., Belanger M., Laroche T., Viertl D., Lashuel H.A., Magistretti P.J. Amyloid-beta aggregates cause alterations of astrocytic metabolic phenotype: impact on neuronal viability. J. Neurosci. 2010, 30:3326-3338.
5. Cimarosti H., Ashikaga E., Jaafari N., Dearden L., Rubin P., Wilkinson K.A., Henley J.M. Enhanced SUMOylation SENP-1 protein levels following oxygen and glucose deprivation in neurones. J. Cereb. Blood Flow Metab. 2012, 32:17-22.
6. DaRocha-Souto B., Scotton T.C., Coma M., Serrano-Pozo A., Hashimoto T., Sereno L., Rodriguez M., Sanchez B., Hyman B.T., Gomez-Isla T. Brain oligomeric beta-amyloid but not total amyloid plaque burden correlates with neuronal loss and astrocyte inflammatory response in amyloid precursor protein/tau transgenic mice. J. Neuropathol. Exp. Neurol. 2011, 70:360-376.
7. Estrada F.S., Hernandez V.S., Lopez-Hernandez E., Corona-Morales A.A., Solis H., Escobar A., Zhang L. Glial activation in a pilocarpine rat model for epileptogenesis: a morphometric and quantitative analysis. Neurosci. Lett. 2012, 514:51-56.
8. Feligioni M., Brambilla E., Camassa A., Sclip A., Arnaboldi A., Morelli F., Antoniou X., Borsello T. Crosstalk between JNK and SUMO signaling pathways: deSUMOylation is protective against H2O2-induced cell injury. PLoS ONE 2011, 6:e28185.
9. Foran E., Bogush A., Goffredo M., Roncaglia P., Gustincich S., Pasinelli P., Trotti D. Motor neuron impairment mediated by a sumoylated fragment of the glial glutamate transporter EAAT2. Glia 2011, 59:1719-1731.
10. Gareau J.R., Lima C.D. The SUMO pathway: emerging mechanisms that shape specificity, conjugation and recognition. Nat. Rev. Mol. Cell Biol. 2010, 11:861-871.
11. Garwood C.J., Pooler A.M., Atherton J., Hanger D.P., Noble W. Astrocytes are important mediators of Abeta-induced neurotoxicity and tau phosphorylation in primary culture. Cell Death Dis. 2011, 2:e167.
12. Hoppe J.B., Frozza R.L., Horn A.P., Comiran R.A., Bernardi A., Campos M.M., Battastini A.M., Salbego C. Amyloid-beta neurotoxicity in organotypic culture is attenuated by melatonin: involvement of GSK-3beta, tau and neuroinflammation. J. Pineal Res. 2010, 48:230-238.
13. Itagaki S., McGeer P.L., Akiyama H., Zhu S., Selkoe D. Relationship of microglia and astrocytes to amyloid deposits of Alzheimer disease. J. Neuroimmunol. 1989, 24:173-182.
14. Lavoie S., Chen Y., Dalton T.P., Gysin R., Cuenod M., Steullet P., Do K.Q. Curcumin, quercetin, and tBHQ modulate glutathione levels in astrocytes and neurons: importance of the glutamate cysteine ligase modifier subunit. J. Neurochem. 2009, 108:1410-1422.
15. Lim G.P., Chu T., Yang F., Beech W., Frautschy S.A., Cole G.M. The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse. J. Neurosci. 2001, 21:8370-8377.
16. Ma Q.L., Yang F., Rosario E.R., Ubeda O.J., Beech W., Gant D.J., Chen P.P., Hudspeth B., Chen C., Zhao Y., Vinters H.V., Frautschy S.A., Cole G.M. Beta-amyloid oligomers induce phosphorylation of tau and inactivation of insulin receptor substrate via c-jun N-terminal kinase signaling: suppression by omega-3 fatty acids and curcumin. J. Neurosci. 2009, 29:9078-9089.
17. McMillan L.E., Brown J.T., Henley J.M., Cimarosti H. Profiles of SUMO and ubiquitin conjugation in an Alzheimer's disease model. Neurosci. Lett. 2011, 502:201-208.
18. Muller S., Berger M., Lehembre F., Seeler J.S., Haupt Y., Dejean A. c-Jun and p53 activity is modulated by SUMO-1 modification. J. Biol. Chem. 2000, 275:13321-13329.
19. Olabarria M., Noristani H.N., Verkhratsky A., Rodriguez J.J. Concomitant astroglial atrophy and astrogliosis in a triple transgenic animal model of Alzheimer's disease. Glia 2010, 58:831-838.
20. Orellana J.A., Shoji K.F., Abudara V., Ezan P., Amigou E., Saez P.J., Jiang J.X., Naus C.C., Saez J.C., Giaume C. Amyloid beta-induced death in neurons involves glial and neuronal hemichannels. J. Neurosci. 2011, 31:4962-4977.
21. Parpura V., Heneka M.T., Montana V., Oliet S.H., Schousboe A., Haydon P.G., Stout R.F., Spray D.C., Reichenbach A., Pannicke T., Pekny M., Pekna M., Zorec R., Verkhratsky A. Glial cells in (patho)physiology. J. Neurochem. 2012, 121:4-27.
22. Ramos A.J., Rubio M.D., Defagot C., Hischberg L., Villar M.J., Brusco A. The 5HT1A receptor agonist, 8-OH-DPAT, protects neurons and reduces astroglial reaction after ischemic damage caused by cortical devascularization. Brain Res. 2004, 1030:201-220.
23. Scapagnini G., Colombrita C., Amadio M., D'Agata V., Arcelli E., Sapienza M., Quattrone A., Calabrese V. Curcumin activates defensive genes and protects neurons against oxidative stress. Antioxid. Redox Signal. 2006, 8:395-403.
24. Scapagnini G., Foresti R., Calabrese V., Giuffrida Stella A.M., Green C.J., Motterlini R. Caffeic acid phenethyl ester and curcumin: a novel class of heme oxygenase-1 inducers. Mol. Pharmacol. 2002, 61:554-561.
25. Simpson J.E., Ince P.G., Lace G., Forster G., Shaw P.J., Matthews F., Savva G., Brayne C., Wharton S.B., Cognitive Function M.R.C. Ageing Neuropathology Study Group, Astrocyte phenotype in relation to Alzheimer-type pathology in the ageing brain. Neurobiol. Aging 2010, 31:578-590.
26. Simpson J.E., Ince P.G., Shaw P.J., Heath P.R., Raman R., Garwood C.J., Gelsthorpe C., Baxter L., Forster G., Matthews F.E., Brayne C., Wharton S.B. M.R.C. Cognitive Function and Ageing Neuropathology Study Group, Microarray analysis of the astrocyte transcriptome in the aging brain: relationship to Alzheimer's pathology and APOE genotype. Neurobiol. Aging 2011, 32:1795-1807.
27. Spilsbury A., Vauzour D., Spencer J.P., Rattray M. Regulation of NF-kappaB activity in astrocytes: effects of flavonoids at dietary-relevant concentrations. Biochem. Biophys. Res. Commun. 2012, 418:578-583.
28. Verkhratsky A., Sofroniew M.V., Messing A., deLanerolle N.C., Rempe D., Rodriguez J.J., Nedergaard M. Neurological diseases as primary gliopathies: a reassessment of neurocentrism. ASN Neuro 2012, 4. pii: e00082.
29. Wang H.M., Zhao Y.X., Zhang S., Liu G.D., Kang W.Y., Tang H.D., Ding J.Q., Chen S.D. PPARgamma agonist curcumin reduces the amyloid-beta-stimulated inflammatory responses in primary astrocytes. J. Alzheimers Dis. 2010, 20:1189-1199.
30. Yang W., Sheng H., Homi H.M., Warner D.S., Paschen W. Cerebral ischemia/stroke and small ubiquitin-like modifier (SUMO) conjugation - a new target for therapeutic intervention?. J. Neurochem. 2008, 106:989-999.
31. Zhang Y.Q., Sarge K.D. Sumoylation of amyloid precursor protein negatively regulates Abeta aggregate levels. Biochem. Biophys. Res. Commun. 2008, 374:673-678.